Jeremy R Edgerton - JoVE Visualize

Showing results (11-20 of 17) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 17 results.

Neuroinformatics|May 29, 2009

Database analysis of simulated and recorded electrophysiological datasets with PANDORA's toolboxCengiz Günay, Jeremy R Edgerton, Su Li, et al.

Molecular Pharmacology|July 7, 2016

Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284Deborah L Smith, Jennifer E Davoren, Jeremy R Edgerton, et al.

Biochemistry|December 14, 2016

Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M<sub>1</sub> Receptor ActivationMichael Popiolek, David P Nguyen, Veronica Reinhart, et al.

ACS Chemical Neuroscience|November 28, 2018

Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of XanomelineCatherine A Thorn, Joshua Moon, Clinton A Bourbonais, et al.

Journal of Medicinal Chemistry|June 10, 2017

Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist ActivityJennifer E Davoren, Michelle Garnsey, Betty Pettersen, et al.

Bioorganic & Medicinal Chemistry Letters|December 4, 2015

Design and optimization of selective azaindole amide M1 positive allosteric modulatorsJennifer E Davoren, Steven V O'Neil, Dennis P Anderson, et al.

Journal of Medicinal Chemistry|June 9, 2016

Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side EffectsJennifer E Davoren, Che-Wah Lee, Michelle Garnsey, et al.

Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 17 results.

Neuroinformatics|May 29, 2009

Database analysis of simulated and recorded electrophysiological datasets with PANDORA's toolboxCengiz Günay, Jeremy R Edgerton, Su Li, et al.

Molecular Pharmacology|July 7, 2016

Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284Deborah L Smith, Jennifer E Davoren, Jeremy R Edgerton, et al.

Biochemistry|December 14, 2016

Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M<sub>1</sub> Receptor ActivationMichael Popiolek, David P Nguyen, Veronica Reinhart, et al.

ACS Chemical Neuroscience|November 28, 2018

Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of XanomelineCatherine A Thorn, Joshua Moon, Clinton A Bourbonais, et al.

Journal of Medicinal Chemistry|June 10, 2017

Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist ActivityJennifer E Davoren, Michelle Garnsey, Betty Pettersen, et al.

Bioorganic & Medicinal Chemistry Letters|December 4, 2015

Design and optimization of selective azaindole amide M1 positive allosteric modulatorsJennifer E Davoren, Steven V O'Neil, Dennis P Anderson, et al.

Journal of Medicinal Chemistry|June 9, 2016

Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side EffectsJennifer E Davoren, Che-Wah Lee, Michelle Garnsey, et al.

Pageof 2